Facing shortages of as many as 280 drugs, the FDA is acting to make sure two life-saving cancer drugs remain available.

FOX News Radio White House Correspondent Mike Majchrowitz reports:

The FDA is acting to make sure two critical cancer drugs remain available despite recent shortages.

The FDA granting a temporary license to a foreign manufacturer to import Lipodox into the U.S. as a replacement drug for Doxil, which is in low supply. Doxil used to treat ovarian and AIDS related cancers, among others.

The FDA also approving new sources of preservative-free Methotrexate, used to treat children with acute lymphocytic leukemia and high-dose therapy of osteosarcoma.

In Washington, Mike Majchrowitz, FOX News Radio